Philip S. Murphy

647 total citations
25 papers, 454 citations indexed

About

Philip S. Murphy is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Philip S. Murphy has authored 25 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Philip S. Murphy's work include Medical Imaging Techniques and Applications (7 papers), Advanced MRI Techniques and Applications (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Philip S. Murphy is often cited by papers focused on Medical Imaging Techniques and Applications (7 papers), Advanced MRI Techniques and Applications (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Philip S. Murphy collaborates with scholars based in United Kingdom, United States and Australia. Philip S. Murphy's co-authors include Martin O. Leach, S Webb, V.P. Cosgrove, M. McJury, Ian J. Rowland, Roger N. Gunn, Elizabeth Adams, M. Brada, A S K Dzik-Jurasz and A.P. Warrington and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Magnetic Resonance in Medicine.

In The Last Decade

Philip S. Murphy

22 papers receiving 442 citations

Peers

Philip S. Murphy

RNMI

PRM

RADIA

ONCOL

Michela Lecchi Italy

Adam Kesner United States

Marcel Segbers Netherlands

Nobuhiko Takai Japan

Stuart Gilchrist United Kingdom

Lena Kaiser Germany

Werner Roser Switzerland

Yasuhiko Ikari Japan

Julie Constanzo France

Michela Lecchi Italy

Philip S. Murphy

285 ×1.3

RNMI

73 ×0.6

PRM

74 ×0.6

RADIA

71 ×1.1

24 ×0.4

ONCOL

Citations per year, relative to Philip S. Murphy Philip S. Murphy (= 1×) peers Michela Lecchi

Countries citing papers authored by Philip S. Murphy

Since Specialization

Citations

This map shows the geographic impact of Philip S. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip S. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip S. Murphy more than expected).

Fields of papers citing papers by Philip S. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip S. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip S. Murphy. The network helps show where Philip S. Murphy may publish in the future.

Co-authorship network of co-authors of Philip S. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Philip S. Murphy. A scholar is included among the top collaborators of Philip S. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip S. Murphy. Philip S. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murphy, Philip S., et al.. (2025). A systematic review of digital and imaging technologies for measuring fatigue in immune mediated inflammatory diseases. npj Digital Medicine. 8(1). 146–146.

Patel, Natasha, Mats Bergström, Philip S. Murphy, & Juliana Maynard. (2025). PET in the characterization of immune diseases and development of therapeutics. PubMed. 6(1). iqaf005–iqaf005.

Calsolaro, Valeria, Rainer Hinz, Joseph Nowell, et al.. (2022). Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals. Molecular Psychiatry. 27(4). 2019–2029. 25 indexed citations

Kershaw, Lucy, Maurits A. Jansen, Andrew Bond, et al.. (2019). Manganese-enhanced MRI: Comparison of agents in the rat pancreas. SHILAP Revista de lepidopterología. 1. 100002–100002. 1 indexed citations

Hoy, Anna M., Natasha McDonald, Ross J. Lennen, et al.. (2018). Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study. Biology Open. 7(7). 14 indexed citations

Tyacke, Robin J., Jim Myers, Ashwin Venkataraman, et al.. (2018). Evaluation of ¹¹C-BU99008, a PET Ligand for the Imidazoline₂ Binding Site in Human Brain. Journal of Nuclear Medicine. 59(10). 1597–1602. 59 indexed citations

Coello, Christopher, Marie Fisk, Divya Mohan, et al.. (2017). Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation. EJNMMI Research. 7(1). 47–47. 29 indexed citations

Fisk, Marie, Divya Mohan, Christopher Coello, et al.. (2016). A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients. OA3506–OA3506. 1 indexed citations

Coello, Christopher, Marie Fisk, Divya Mohan, et al.. (2016). Quantitative analysis of dynamic 18F-FDG in lungs of HV and COPD subjects. 57. 482–482.

10.

Saleem, Azeem, Graham E. Searle, Laura Kenny, et al.. (2015). Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer. EJNMMI Research. 5(1). 30–30. 58 indexed citations

11.

Saleem, Azeem, Graham E. Searle, Laura Kenny, et al.. (2013). Brain and tumor penetration of carbon-11–labeled lapatinib ([¹¹C]Lap) in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC).. Journal of Clinical Oncology. 31(15_suppl). 635–635. 2 indexed citations

12.

Cobbold, Jeremy, Mary M.E. Crossey, Peter G. Colman, et al.. (2009). Optimal combinations of ultrasound‐based and serum markers of disease severity in patients with chronic hepatitis C. Journal of Viral Hepatitis. 17(8). 537–545. 31 indexed citations

13.

Murphy, Philip S. & Mats Bergström. (2009). Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective. Current Pharmaceutical Design. 15(9). 957–965. 11 indexed citations

14.

Yau, CC, C. Martin Curtis, Philip S. Murphy, et al.. (2009). 1206 Phase I study of Pazopanib (PAZ) in Hepatocellular Carcinoma (HCC): evaluation of clinical activity, Pharmacokinetics (PK), and Dynamic Contrast Enhanced MRI (DCE-MRI). European Journal of Cancer Supplements. 7(2). 122–122. 3 indexed citations

15.

Reid, David G. & Philip S. Murphy. (2008). Hydrophobicity predicts in vivo ¹⁹F magnetic resonance detectability of fluorinated psychiatric drugs: simple test for likely success in clinical pharmacokinetic studies. Drug Development Research. 69(5). 279–283. 4 indexed citations

16.

Murphy, Philip S., Ian J. Rowland, Louis Viviers, et al.. (2003). Could assessment of glioma methylene lipid resonance byin vivo¹H-MRS be of clinical value?. British Journal of Radiology. 76(907). 459–463. 41 indexed citations

17.

Murphy, Philip S., Mark George, David J. Collins, et al.. (2002). Human rectal adenocarcinoma: Demonstration of ¹H‐MR spectra in vivo at 1.5 T. Magnetic Resonance in Medicine. 47(4). 809–811. 29 indexed citations

18.

Murphy, Philip S., V.P. Cosgrove, Adam J. Schwarz, S Webb, & Martin O. Leach. (2000). Proton spectroscopic imaging of polyacrylamide gel dosimeters for absolute radiation dosimetry. Physics in Medicine and Biology. 45(4). 835–845. 27 indexed citations

19.

Cosgrove, V.P., Philip S. Murphy, M. McJury, et al.. (2000). The reproducibility of polyacrylamide gel dosimetry applied to stereotactic conformal radiotherapy. Physics in Medicine and Biology. 45(5). 1195–1210. 52 indexed citations

20.

McJury, M., V.P. Cosgrove, Philip S. Murphy, et al.. (1999). Experimental 3D dosimetry around a high-dose-rate clinical¹⁹²Ir source using a polyacrylamide gel (PAG) dosimeter. Physics in Medicine and Biology. 44(10). 2431–2444. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact